Anti-APP A4 , clone 22C11-L, Recombinant Mouse Monoclonal Ab
克隆号:22C11-L
ICC IHC WB
EMS0016
货号 规格 数量. 价格 库存
EMS0016-25μg 25μg
EMS0016-100μg 100μg
EMS0016-500μg 500μg
应用
Immunocytochemistry (ICC): 1:100
Immunohistochemistry (IHC): 1:100
Western Blotting (WB): 1:1,000
产品信息
Reactive Species Human, Mouse, Rat
Target UniProt ID P05067
Target Alternative Names ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein
Target Molecular Weight (kDa) 110 kDa
Sensitivity Endogenous
Host / lsotype Mouse / IgG1
Class Recombinant Antibody
Clone 22C11-L
Expression System CHO
Immunogen Recombinant protein of APP A4.
Purification Protein G
Conjugate Unconjugated
Form Liquid
Concentration 0.5 mg/mL
Storage Buffer PBS, 40% Glycerol, 0.05% BSA, 0.04% Proclin 300
Storage Condition -20°C
背景
APP A4 (Amyloid Precursor Protein A4) is a precursor protein that is primarily expressed in neurons and is best known for its association with Alzheimer's disease. APP undergoes proteolytic cleavage by enzymes, such as secretases, resulting in the production of various fragments, including beta-amyloid (Aβ) peptides. These peptides can aggregate to form amyloid plaques, a hallmark feature of Alzheimer's disease. While APP A4 is implicated in neurodegeneration, it also plays a role in normal cellular processes like cell signaling, growth, and synaptic function. The study of APP and its cleaved products, particularly Aβ, is central to understanding the mechanisms underlying Alzheimer's disease and developing potential therapeutic strategies.
参考文献
Caporaso, G.L. et al. (1992) Proc Natl Acad Sci USA 89, 3055-9.